Mimedx Group, INC DEF 14A proxy statements

MIMEDX Group, Inc. has scheduled its 2025 Annual Meeting of Shareholders for June 18, 2025, where key proposals include the election of nine directors, advisory approval of executive compensation, auditor ratification, and an amendment to the 2016 Equity and Cash Incentive Plan.

MiMedx Group is asking shareholders to approve an amendment to its 2016 Equity and Cash Incentive Plan to increase the number of shares available for issuance by 7,950,000, aiming to attract and retain key talent.

MiMedx Group, Inc. has filed a definitive proxy statement with the SEC.

MiMedx Group will hold its 2024 annual meeting of shareholders virtually on June 5, 2024, to vote on director elections, executive compensation, and the ratification of its independent accounting firm.